Cargando…

Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19

Detalles Bibliográficos
Autores principales:	Castelli, Maxime, Maurin, Arnaud, Bartoli, Axel, Dassa, Michael, Marchi, Baptiste, Finance, Julie, Lagier, Jean-Christophe, Million, Matthieu, Parola, Philippe, Brouqui, Philippe, Raoult, Didier, Cortaredona, Sebastien, Jacquier, Alexis, Gaubert, Jean-Yves, Habert, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885760/ https://www.ncbi.nlm.nih.gov/pubmed/33594500 http://dx.doi.org/10.1186/s13244-020-00950-y

Ejemplares similares

Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19
por: Castelli, Maxime, et al.
Publicado: (2020)

Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score
por: Leger, Thomas, et al.
Publicado: (2020)

Value and prognostic impact of a deep learning segmentation model of COVID-19 lung lesions on low-dose chest CT
por: Bartoli, Axel, et al.
Publicado: (2022)

Asymptomatic hypoxia in COVID-19 is associated with poor outcome
por: Brouqui, Philippe, et al.
Publicado: (2021)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2022)

Olfactory and gustative disorders for the diagnosis of COVID-19
por: Boudjema, Sophia, et al.
Publicado: (2020)

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2020)

WITHDRAWN: Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
por: Million, Matthieu, et al.
Publicado: (2021)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
por: Brouqui, Philippe, et al.
Publicado: (2023)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19
por: Finance, Julie, et al.
Publicado: (2021)

Life-years lost by COVID-19 patients in public hospitals of Marseille (APHM-South-Eastern France): a limited death toll: a retrospective analysis
por: Arlotto, Sylvie, et al.
Publicado: (2021)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
por: Osman, Ikram Omar, et al.
Publicado: (2021)

Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults
por: Colson, Philippe, et al.
Publicado: (2020)

Lack of MERS Coronavirus but Prevalence of Influenza Virus in French Pilgrims after 2013 Hajj
por: Gautret, Philippe, et al.
Publicado: (2014)

Long-Term Persistence of Olfactory and Gustatory Disorders in COVID-19 Patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Who Were Hospitalized Deceased Patients from COVID-19 During the First Year of Pandemic? Retrospective Analysis of 1104 Deceased Patients in South of France
por: Arlotto, Sylvie, et al.
Publicado: (2022)

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France
por: Hoang, Van-Thuan, et al.
Publicado: (2021)

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
por: Gautret, Philippe, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Does spitting in public play a role in transmitting SARS-CoV-2?
por: Gautret, Philippe, et al.
Publicado: (2020)

Evaluation of pain susceptibility by taking blood pressure in patients with infections: A prospective comparative study
por: Eldin, Carole, et al.
Publicado: (2021)

Rickettsia slovaca and R. raoultii in Tick-borne Rickettsioses
por: Parola, Philippe, et al.
Publicado: (2009)

Thromboses in tuberculosis are linked to antiphosphatidylethanolamine antibodies levels: A cross-sectional study
por: Bessis, Simon, et al.
Publicado: (2019)

Infections in symptomatic travelers returning from the Arabian peninsula to France: A retrospective cross-sectional study
por: Griffiths, Karolina, et al.
Publicado: (2016)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Subcutaneous Infection with Dirofilaria immitis Nematode in Human, France
por: Foissac, Maud, et al.
Publicado: (2013)

Human Infection Caused by Leptospira fainei
por: Arzouni, Jean-Pierre, et al.
Publicado: (2002)

SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021
por: Fournier, Pierre-Edouard, et al.
Publicado: (2022)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
por: Amrane, Sophie, et al.
Publicado: (2020)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
por: Dao, Thi Loi, et al.
Publicado: (2021)

Clostridium tetani Osteitis without Tetanus
por: Levy, Pierre-Yves, et al.
Publicado: (2014)

Identification of dengue type 2 virus in febrile travellers returning from Burkina Faso to France, related to an ongoing outbreak, October to November 2016
por: Eldin, Carole, et al.
Publicado: (2016)

Eosinophilic Pleural Effusion in Gnathostomiasis
por: Parola, Philippe, et al.
Publicado: (2004)

Human Gut Microbiota: Repertoire and Variations
por: Lagier, Jean-Christophe, et al.
Publicado: (2012)

Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen
por: Dubourg, Grégory, et al.
Publicado: (2016)

Different pattern of the second outbreak of COVID-19 in Marseille, France
por: Gautret, Philippe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ulp422rj4bkn3kgbp1iifdng8r